Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

A-Alpha Bio
Fluke Hall, Suite 304
4000 Mason Road
Seattle, WA 98195
Phone: 858-405-7116
https://www.aalphabio.com/

A-Alpha Bio has developed a genetically engineered platform technology, called AlphaSeq, for measuring interactions between proteins that can be used to discover and optimize life-saving drugs. AlphaSeq was invented and developed by A-Alpha Bio's founders Drs. David Younger and Randolph Lopez, and Scientific Advisors, Drs. David Baker and Eric Klavins, at the University of Washington (UW). AlphaSeq enables the measurement of millions of interactions between proteins with high quantitative accuracy.

Key Contact
Name
Dr. David Younger
Title
CEO
Funding Events

Date
Amount
Type
Investors
09/27/19 $2,800,000 Seed AME Cloud Ventures
Boom Capital
Madrona Venture Group
OS Fund
Sahsen Ventures
Washington Research Foundation
09/08/21 $20,000,000 Series A Lux Capital
Madrona Venture Group
Perceptive Advisors


Featured Reading